Chief Executive Officer – Jonathan Schwartz, MBA
Jonathan holds an MBA in Finance from New York University in 1991. Most recently Jonathan was a financial officer at MADA Energie Ltd., Jerusalem, responsible for determining IRR value of potential projects. Previously Jonathan served as an investment banker at Avalon Capital focusing on the healthcare sector. Prior to that, Jonathan was Manager of Business Development and Finance at Pronto Diagnostics, a molecular diagnostic company in Israel. At Pronto Jonathan successfully created commercial agreements with Novartis and Kamada generating millions of dollars in revenues to the Company and its affiliate. Earlier Jonathan served as a Corporate Consultant at PricewaterhouseCoopers where his clients primarily came from the Medical Device and Pharmaceuticals industries. Jonathan started his career as an equity analyst and portfolio manager on Wall Street.